Description

1H-Imidazo[4,5-B][1,2,5]Oxadiazolo[3,4-E]Pyrazin-6(4H)-One,4A,5,7,7A-Tetrahydro-(9Ci) CAS NO 132497-20-2 is a high-purity, complex heterocyclic compound serving as a critical advanced intermediate in pharmaceutical research and development. Its intricate fused-ring structure makes it a valuable building block for synthesizing novel active pharmaceutical ingredients (APIs) with potential therapeutic applications. This compound is primarily utilized by research institutions and pharmaceutical companies engaged in the discovery and development of new drug candidates, particularly in areas requiring sophisticated molecular scaffolds.

Application

• Pharmaceutical Intermediate: Serves as a key precursor in the multi-step synthesis of novel drug candidates, especially in oncology and central nervous system (CNS) therapeutic areas.
• Medicinal Chemistry Research: Used as a sophisticated scaffold for structure-activity relationship (SAR) studies and library synthesis to explore new chemical entities.
• Bioconjugation & Probe Development: Acts as a specialized linker or core structure in the development of biochemical probes and diagnostic agents.
• Process Chemistry & Scale-Up: Employed in route scouting and optimization studies for the commercial-scale production of target molecules.
• Academic Research: Utilized in universities and research institutes for fundamental studies in heterocyclic chemistry and reaction methodology.

Basic Information

Item	Details
Product Name	1H-Imidazo[4,5-B][1,2,5]Oxadiazolo[3,4-E]Pyrazin-6(4H)-One,4A,5,7,7A-Tetrahydro-(9Ci)
CAS No.	132497-20-2
Molecular Formula	C7H6N6O2
Molecular Weight	206.16 g/mol
Synonyms	4a,5,7,7a-Tetrahydro-1H-imidazo[4,5-b][1,2,5]oxadiazolo[3,4-e]pyrazin-6(4H)-one; 1H-Imidazo[4,5-b][1,2,5]oxadiazolo[3,4-e]pyrazin-6(4H)-one, 4a,5,7,7a-tetrahydro-; 132497-20-2; Tetrahydro-imidazo-oxadiazolo-pyrazinone; Fused triazolopyrazine derivative; Advanced heterocyclic intermediate; Pharmaceutical building block 132497-20-2
EINECS	Contact for details

Quality Control

Our production of 1H-Imidazo[4,5-B][1,2,5]Oxadiazolo[3,4-E]Pyrazin-6(4H)-One,4A,5,7,7A-Tetrahydro-(9Ci) adheres to stringent quality protocols to ensure batch-to-batch consistency and high purity, essential for sensitive R&D applications. We provide comprehensive Certificates of Analysis (COA) with each batch, detailing purity, identity, and impurity profiles. Our quality systems are designed to support cGMP and ISO standards for research-grade materials, ensuring traceability and reliability for our global clientele.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (typically 15-25°C). This compound is light-sensitive (store away from light) and should be handled under appropriate conditions to maintain stability. For long-term storage, consider inert atmosphere conditions to prevent potential degradation.

Specification

Item	Specification
Appearance	White to off-white solid
Identification (IR)	Conforms to structure
Purity (HPLC)	≥ 97.0%
Related Substances (HPLC)	Total impurities ≤ 3.0%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.